

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 67.88 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 91.69 | Oscillator | Sell |
| Williams %R (14) | -5.66 | Oscillator | Sell |
| MACD (12, 26, 9) | 6.92 (Hist 9.23) | Oscillator | Strong Buy |
| Average Directional Index (14) | 35.15 (+DI 34.9 / -DI 11.9) | Trend | Strong Buy |
| EMA 20 | 514.66 | MA | Strong Buy |
| SMA 20 | 501.07 | MA | Strong Buy |
| EMA 50 | 519.61 | MA | Strong Buy |
| SMA 50 | 522.39 | MA | Strong Buy |
| SMA 200 | 592.69 | MA | Strong Sell |
Stock news · updated daily
Northrop Grumman (NOC) delivered stronger results than I expected in 2026, with a record $109.6 billion backlog and robust project execution. NOC's Aeronautics segment outperformed, with 14.41% revenue and 135.67% EBIT growth, driven by B-21 and F-35 volume and margin recovery. Relative valuation frameworks indicate 22–54% upside potential for NOC, supporting a reiterated BUY rating despite margin and contract risks.
Lockheed Martin (NYSE:LMT | LMT Price Prediction) stock rose 9% to $602.75 on Thursday after the company reported third-quarter results that topped estimates and raised its full-year outlook on the back of a record backlog.
Northrop Grumman (NYSE: NOC) reported third-quarter 2026 sales growth across all four business segments, record backlog and higher earnings guidance, as the defense contractor cited demand for strategic deterrence, space systems, missile production and autonomous technologies. Chair, CEO and President Kathy Warden said the company's third-quarter results reflected "strong and disciplined execution" across its portfolio. Northrop
Pentagon contracts lock in cash flows years before a dividend check ever gets cut, and four defense giants are sitting on backlogs that stretch well into the next decade.
Northrop Grumman targets 5%-7% sales growth in 2027, backed by a record backlog and B-21 investments, while higher capital spending adds execution challenges.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BAESY secures a U.S. Space Force contract to develop advanced SATCOM terminals, strengthening its position in the growing military satellite communications market.
Northrop Grumman Corporation (NYSE:NOC) on Tuesday reported better-than-expected third-quarter earnings and raised its FY26 adjusted EPS guidance.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Oct 20, 2026 | 7.18 | 7.89 | Beat 9.9% | $11.12B |
| Jul 21, 2026 | 6.82 | 7.68 | Beat 12.6% | $10.88B |
| Apr 21, 2026 | 6.06 | 6.14 | Beat 1.3% | $9.88B |
| Jan 27, 2026 | 6.98 | 7.23 | Beat 3.6% | $11.71B |
| Oct 21, 2025 | 6.44 | 7.67 | Beat 19.1% | $10.42B |
| Jul 22, 2025 | 6.92 | 7.11 | Beat 2.7% | $10.35B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 10-Q | Oct 20, 2026 | 2026-10-20 16:01:50 | View |
| 3/A | Oct 20, 2026 | 2026-10-20 15:47:54 | View |
| 8-K | Oct 20, 2026 | 2026-10-20 06:00:28 | View |
| 4 | Oct 1, 2026 | 2026-10-01 11:07:12 | View |
| 4 | Oct 1, 2026 | 2026-10-01 11:04:44 | View |
| 4 | Aug 21, 2026 | 2026-08-21 17:10:25 | View |
| 8-K | Aug 21, 2026 | 2026-08-21 17:06:25 | View |
| SC 13G/A | Aug 12, 2026 | 2026-08-12 10:28:16 | View |
| 4 | Aug 4, 2026 | 2026-08-04 13:45:58 | View |
| 10-Q | Jul 21, 2026 | 2026-07-21 16:02:01 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | NOC | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 17.4x | 19.3x · sector 18.4x | In line |
| Forward P/E (FY26E) | 18.8x | EPS est. 29.37 | In line |
| Price / Book | 4.2x | 4.9x | In line |
| Price / Sales | 1.8x | 1.9x | In line |
| EV / EBITDA | 12.3x | 13.5x | In line |
| Return on equity | 25.7% | — | Top tier |
| Gross margin | 20.0% | 19.5% | In line |
| Debt / Equity | 0.89 | 1.21 | Moderate |
| Piotroski / Altman Z | 8/9 | Z 3.16 | Safe zone |
Discounted cash flow model
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Feb 12, 26 | Grady Christopher W. | director | 0 | — | |
| Sep 30, 26 | Krishna Arvind | director | A-Award | 75 @ $483.48 | $36.26K |
| Sep 30, 26 | Brown Marianne Catherine | director | A-Award | 96 @ $483.48 | $46.41K |
| Aug 19, 26 | Warden Kathy J | director, officer: Chair, CEO and President | A-Award | 35,910 | — |
| Aug 3, 26 | Welsh Mark A Iii | director | S-Sale | 8 @ $544.53 | $4.36K |
| Aug 3, 26 | Welsh Mark A Iii | director | S-Sale | 19 @ $545.59 | $10.37K |
| Aug 3, 26 | Welsh Mark A Iii | director | S-Sale | 11 @ $546.42 | $6.01K |
| Aug 3, 26 | Welsh Mark A Iii | director | S-Sale | 31 @ $547.42 | $16.97K |
Current price $551.55
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 22, 26 | Barclays | maintain | Underweight | Underweight |
| Oct 21, 26 | BNP Paribas | maintain | Outperform | Outperform |
| Oct 21, 26 | Baird | upgrade | Neutral | Outperform |
| Oct 21, 26 | RBC Capital | maintain | Sector Perform | Sector Perform |
| Oct 21, 26 | Guggenheim | maintain | Buy | Buy |
| Oct 21, 26 | UBS | maintain | Buy | Buy |
| Oct 21, 26 | Morgan Stanley | maintain | Overweight | Overweight |
| Oct 14, 26 | Bernstein | maintain | Market Perform | Market Perform |
| Oct 9, 26 | TD Cowen | maintain | Hold | Hold |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure